These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 20831510)

  • 1. Dose- and LET-painting with particle therapy.
    Bassler N; Jäkel O; Søndergaard CS; Petersen JB
    Acta Oncol; 2010 Oct; 49(7):1170-6. PubMed ID: 20831510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LET-painting increases tumour control probability in hypoxic tumours.
    Bassler N; Toftegaard J; Lühr A; Sørensen BS; Scifoni E; Krämer M; Jäkel O; Mortensen LS; Overgaard J; Petersen JB
    Acta Oncol; 2014 Jan; 53(1):25-32. PubMed ID: 24020629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose and dose averaged LET comparison of ¹H, ⁴He, ⁶Li, ⁸Be, ¹⁰B, ¹²C, ¹⁴N, and ¹⁶O ion beams forming a spread-out Bragg peak.
    Kantemiris I; Karaiskos P; Papagiannis P; Angelopoulos A
    Med Phys; 2011 Dec; 38(12):6585-91. PubMed ID: 22149840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depth absorbed dose and LET distributions of therapeutic 1H, 4He, 7Li, and 12C beams.
    Kempe J; Gudowska I; Brahme A
    Med Phys; 2007 Jan; 34(1):183-92. PubMed ID: 17278503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour control in ion beam radiotherapy with different ions in the presence of hypoxia: an oxygen enhancement ratio model based on the microdosimetric kinetic model.
    Strigari L; Torriani F; Manganaro L; Inaniwa T; Dalmasso F; Cirio R; Attili A
    Phys Med Biol; 2018 Mar; 63(6):065012. PubMed ID: 28862152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose or 'LET' painting--What is optimal in particle therapy of hypoxic tumors?
    Malinen E; Søvik Å
    Acta Oncol; 2015; 54(9):1614-22. PubMed ID: 26198655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment planning of intensity modulated composite particle therapy with dose and linear energy transfer optimization.
    Inaniwa T; Kanematsu N; Noda K; Kamada T
    Phys Med Biol; 2017 Jun; 62(12):5180-5197. PubMed ID: 28333688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling of the oxygen enhancement ratio for ion beam radiation therapy.
    Wenzl T; Wilkens JJ
    Phys Med Biol; 2011 Jun; 56(11):3251-68. PubMed ID: 21540489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LET spectra at different penetration depths along secondary 9C and 11C beams.
    Li Q; Komori M; Kanai T; Kitagawa A; Urakabe E; Kanazawa M; Tomitani T; Sato S
    Phys Med Biol; 2004 Nov; 49(22):5119-33. PubMed ID: 15609562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in radiotherapy.
    Svensson H; Möller TR;
    Acta Oncol; 2003; 42(5-6):430-42. PubMed ID: 14596505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes.
    Antonovic L; Lindblom E; Dasu A; Bassler N; Furusawa Y; Toma-Dasu I
    J Radiat Res; 2014 Sep; 55(5):902-11. PubMed ID: 24728013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on the physical dose filtered by linear energy transfer for treatment plan evaluation in carbon ion therapy.
    Schafasand M; Resch AF; Nachankar A; Gora J; Traneus E; Glimelius L; Georg D; Stock M; Carlino A; Fossati P
    Med Phys; 2024 Jan; 51(1):556-565. PubMed ID: 37727137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer.
    Tilly N; Johansson J; Isacsson U; Medin J; Blomquist E; Grusell E; Glimelius B
    Phys Med Biol; 2005 Jun; 50(12):2765-77. PubMed ID: 15930601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for shoot-through FLASH proton therapy.
    Verhaegen F; Wanders RG; Wolfs C; Eekers D
    Phys Med Biol; 2021 Mar; 66(6):06NT01. PubMed ID: 33571981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-High Dose-Rate, Pulsed (FLASH) Radiotherapy with Carbon Ions: Generation of Early, Transient, Highly Oxygenated Conditions in the Tumor Environment.
    Zakaria AM; Colangelo NW; Meesungnoen J; Azzam EI; Plourde MÉ; Jay-Gerin JP
    Radiat Res; 2020 Dec; 194(6):587-593. PubMed ID: 32853343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of SCCVII tumor cell survival in clamped and non-clamped solid tumors exposed to carbon-ion beams in comparison to X-rays.
    Hirayama R; Uzawa A; Takase N; Matsumoto Y; Noguchi M; Koda K; Ozaki M; Yamashita K; Li H; Kase Y; Matsufuji N; Koike S; Masunaga S; Ando K; Okayasu R; Furusawa Y
    Mutat Res; 2013 Aug; 756(1-2):146-51. PubMed ID: 23735375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.
    Wenzl T; Wilkens JJ
    Radiat Oncol; 2011 Dec; 6():171. PubMed ID: 22172079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculated LET spectrum from antiproton beams stopping in water.
    Bassler N; Holzscheiter M
    Acta Oncol; 2009; 48(2):223-6. PubMed ID: 18932095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.